CliffBio
small molecule

NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

NICARDIPINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameNICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Active ingredientNICARDIPINE HYDROCHLORIDE
Strength20MG/200ML (0.1MG/ML)
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalSeptember 2024
Marketing statusRX

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE patent cliff — loss of exclusivity — | CliffBio